Uveitis, Anterior, Nongranulomatous
- Author: Andrew A Dahl, MD, FACS; Chief Editor: Hampton Roy, Sr, MD more...
Iritis, or anterior uveitis, is the most common form of intraocular inflammation. It is a common cause of a painful red eye. Inflammation of the iris may appropriately be termed iritis, whereas inflammation of the iris and the ciliary body is called iridocyclitis. Iritis may be subdivided into 2 broad categories: granulomatous and nongranulomatous.
This article discusses nongranulomatous iritis, although iritis due to a granulomatous disease process may have a nongranulomatous appearance. For information about granulomatous disease, see Uveitis, Anterior, Granulomatous. The most common form of nongranulomatous anterior uveitis is acute anterior uveitis (AAU), which is associated with the human leukocyte antigen (HLA)–B27 allele in one half to two thirds of cases. However, only 1% of people who carry the HLA-B27 allele develop acute anterior uveitis.
The exact pathophysiology is not known. Inflammation of the iris and the ciliary body causes a breakdown of the blood-ocular barrier. This condition allows both protein and WBCs to extravasate into the aqueous, resulting in the typical iritis signs of cell and flare. Frequently, the cause is idiopathic, but certain ocular and systemic diseases may be the underlying cause of the iritis.
In the case of HLA-B27–associated acute anterior uveitis, speculation about molecular mimicry has yet to be substantiated in humans. Certainly, recent interest in the microbiome (gut and other resident micro-organisms) in disease, as well as the observation that rats transgenic for HLA-B27 do not form ankylosis and other evidence of disease until the gut is colonized, suggest a possible connection to disease. A close relationship between asymptomatic (subclinical) ileocolitis has been demonstrated in patients with recurrent uveitis.
Iritis is the most frequent form of uveitis encountered by ophthalmologists. In one community-based study, anterior uveitis accounted for more than 90% of all cases of uveitis. The annual incidence rate is approximately 8 cases per 100,000 population.
No particular geographic distribution for iritis has been noted.
Morbidity arises from iritis and any associated disease process, if present.
Episodes of acute anterior uveitis are often associated with pain, photophobia, decreased vision, and the need for follow-up visits, all of which affect quality of life.
Patients may develop posterior synechiae, and, if severe, a secluded pupil and subsequent angle-closure glaucoma may result.
Associated ocular complications (eg, cataract, glaucoma, macular edema, hypotony) may result in severe vision loss.
No significant racial differences exist. HLA-B27–associated anterior uveitis is more common in whites.
No significant sexual differences exist. However, the male-to-female ratio of ankylosing spondylitis, which is a common cause of iritis, is 3:1.
Iritis may develop in persons of any age but most commonly in the fourth and fifth decades of life.
Smith JR. HLA-B27--associated uveitis. Ophthalmol Clin North Am. 2002 Sep. 15(3):297-307. [Medline].
Ali A, Samson CM. Seronegative spondyloarthropathies and the eye. Curr Opin Ophthalmol. 2007 Nov. 18(6):476-80. [Medline].
Pleyer U, Forrester JV. Uveitis and Immunological Disorders. Essentials in Ophthalmology. Springer; 2009.
McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996 Jan. 121(1):35-46. [Medline].
Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007 Apr 21. 369(9570):1379-90. [Medline].
Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis?. Ocul Immunol Inflamm. 2011 Apr. 19(2):139-44. [Medline].
Suzuki T, Ohashi Y. Corneal endotheliitis. Semin Ophthalmol. 2008 Jul-Aug. 23(4):235-40. [Medline].
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep. 140(3):509-16. [Medline].
Birnbaum AD, Jiang Y, Vasaiwala R, Tessler HH, Goldstein DA. Bilateral simultaneous-onset nongranulomatous acute anterior uveitis: clinical presentation and etiology. Arch Ophthalmol. 2012 Nov. 130(11):1389-94. [Medline].
Vitale AT, Graham E, de Boer JH. Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inflamm. 2013 Dec. 21(6):478-85. [Medline].
Kruh JN, Yang P, Suelves AM, Foster CS. Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up. Ophthalmology. 2014 Jan. 121(1):358-64. [Medline].
Rosenbaum JT, Smith JR. Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol. 2002 Nov-Dec. 20(6 Suppl 28):S143-5. [Medline].
Braakenburg AM, de Valk HW, de Boer J, Rothova A. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol. 2008 Mar. 145(3):472-9. [Medline].
[Guideline] Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000 Oct. 130(4):492-513. [Medline].
Jap A, Chee SP. Immunosuppressive therapy for ocular diseases. Curr Opin Ophthalmol. 2008 Nov. 19(6):535-40. [Medline].
Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005 Jul. 112(7):1287-92. [Medline].
Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014 Mar. 121(3):785-96.e3. [Medline].
Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology. 2007 May. 114(5):995-9. [Medline].
Menezo V, Lightman S. The development of complications in patients with chronic anterior uveitis. Am J Ophthalmol. 2005 Jun. 139(6):988-92. [Medline].
Nussenblatt RB, Whitcup SM. Uveitis. Fundamentals and Clinical Practice. 3rd ed. 2003.
Pepose JS, Holland GN, Wilhelmus KR. Ocular Infection and Immunity. 1996.
Rodrigues EB, Farah ME, Maia M, et al. Therapeutic monoclonal antibodies in ophthalmology. Prog Retin Eye Res. 2009 Mar. 28(2):117-44. [Medline].
Rosenbaum JT, George RK. Uveitis. Current Ocular Therapy 5. 2000. 519-21.